Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present data analyses from its movement disorder programs, including INGREZZA® (valbenazine) capsules, the first U.S. Food and...

CLARK, N.J., Sept. 17, 2019 – GEP, a leading provider of supply chain and procurement solutions to Fortune 500 and Global 2000 enterprises worldwide, announced today that former PepsiCo CEO...

Scientific Games Corporation (NASDAQ: SGMS) ("Scientific Games" or the "Company") will showcase products, technology and services that responsibly power lottery profits for beneficiaries at the...

Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today...

Amgen (NASDAQ:AMGN) today announced that new data from its oncology pipeline and marketed product portfolio will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress in...